Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Eyepoint Pharmaceuticals Inc (EYPT)

Eyepoint Pharmaceuticals Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 645,427
  • Shares Outstanding, K 53,518
  • Annual Sales, $ 46,020 K
  • Annual Income, $ -70,800 K
  • EBIT $ -99 M
  • EBITDA $ -99 M
  • 60-Month Beta 1.50
  • Price/Sales 13.68
  • Price/Cash Flow N/A
  • Price/Book 2.69

Options Overview Details

View History
  • Implied Volatility 68.67% ( -19.00%)
  • Historical Volatility 100.81%
  • IV Percentile 10%
  • IV Rank 13.14%
  • IV High 406.22% on 11/15/23
  • IV Low 17.61% on 07/18/24
  • Put/Call Vol Ratio 0.36
  • Today's Volume 173
  • Volume Avg (30-Day) 703
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 12,213
  • Open Int (30-Day) 10,711

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.52
  • Number of Estimates 5
  • High Estimate -0.40
  • Low Estimate -0.67
  • Prior Year -0.33
  • Growth Rate Est. (year over year) -57.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.88 +53.05%
on 10/02/24
13.98 -13.76%
on 10/28/24
+4.06 (+50.75%)
since 10/01/24
3-Month
7.40 +62.97%
on 08/14/24
13.98 -13.76%
on 10/28/24
+2.93 (+32.09%)
since 08/01/24
52-Week
5.86 +105.98%
on 11/22/23
30.99 -61.08%
on 02/08/24
+4.82 (+66.57%)
since 11/01/23

Most Recent Stories

More News
EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

EYPT : 12.06 (+2.55%)
EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering

EYPT : 12.06 (+2.55%)
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

EYPT : 12.06 (+2.55%)
EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYUâ„¢ for Diabetic Macular Edema

EYPT : 12.06 (+2.55%)
EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration

EYPT : 12.06 (+2.55%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EYPT : 12.06 (+2.55%)
EyePoint Pharmaceuticals: Q2 Earnings Snapshot

EyePoint Pharmaceuticals: Q2 Earnings Snapshot

EYPT : 12.06 (+2.55%)
2 Small-Cap Stocks Under $20 With Over 220% Upside Potential

Wall Street is forecasting multibagger returns from these two small-cap biotech stocks over the next year.

LLY : 818.93 (-1.30%)
NVO : 111.94 (-0.01%)
MRK : 101.88 (-0.43%)
EYPT : 12.06 (+2.55%)
ALT : 6.74 (unch)
Stocks Settle Higher on Solid Earnings and Fed Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.13%. US stock indexes...

$SPX : 5,728.80 (+0.41%)
SPY : 571.04 (+0.42%)
$DOWI : 42,052.19 (+0.69%)
DIA : 420.42 (+0.66%)
$IUXX : 20,033.14 (+0.72%)
QQQ : 487.43 (+0.74%)
ZNZ24 : 110-010s (-0.40%)
SMCI : 26.05 (-10.51%)
NVDA : 135.40 (+1.99%)
AMD : 141.86 (-1.53%)
KLAC : 669.38 (+0.47%)
AVGO : 168.92 (-0.50%)
Stocks Climb on Strength in Chips Stocks and Fed Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. US stock indexes this morning...

$SPX : 5,728.80 (+0.41%)
SPY : 571.04 (+0.42%)
$DOWI : 42,052.19 (+0.69%)
DIA : 420.42 (+0.66%)
$IUXX : 20,033.14 (+0.72%)
QQQ : 487.43 (+0.74%)
ZNZ24 : 110-010s (-0.40%)
MU : 99.73 (+0.08%)
NVDA : 135.40 (+1.99%)
AMD : 141.86 (-1.53%)
GFS : 36.63 (+0.36%)
KLAC : 669.38 (+0.47%)

Business Summary

EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 13.74
2nd Resistance Point 13.11
1st Resistance Point 12.58
Last Price 12.06
1st Support Level 11.42
2nd Support Level 10.79
3rd Support Level 10.26

See More

52-Week High 30.99
Fibonacci 61.8% 21.39
Fibonacci 50% 18.42
Fibonacci 38.2% 15.46
Last Price 12.06
52-Week Low 5.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar